CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma
Yongjun Cha, Yu Jung Kim, Se-Hoon Lee, Tae-Min Kim, Seung Hong Choi, Dong-Wan Kim, Chul-Kee Park, Il Han Kim, Jee Hyun Kim, Eunhee Kim, Byungse Choi, Chae-Yong Kim, In Ah Kim, Dae Seog Heo
Cancer Research and Treatment. 2017;49(1):129-140.   Published online 2016 May 18    DOI: https://doi.org/10.4143/crt.2015.466

Excel Download

Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma
Cancer Research and Treatment. 2017;49(1):129-140   Crossref logo
Link1 Link2 Link3

Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients
Radiation Oncology. 2014;9(1):   Crossref logo
Link1 Link2 Link3 Link4

Bevacizumab in recurrent malignant glioma
Current Neurology and Neuroscience Reports. 2008;8(3):233-234   Crossref logo
Link1 Link2 Link3

Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study
Japanese Journal of Clinical Oncology. 2019;49(11):1016-1023   Crossref logo
Link1 Link2

Impact of adverse events of bevacizumab on survival outcomes of patients with recurrent glioblastoma
Journal of Clinical Neuroscience. 2020;74:36-40   Crossref logo
Link1 Link2

PO-0798: Bevacizumab treatment in recurrent malignant glioma patients – mono-institutional experience in 125 patients
Radiotherapy and Oncology. 2015;115:S400   Crossref logo
Link1 Link2

8747 POSTER Single Agent Bevacizumab for Recurrent Malignant Glioma
European Journal of Cancer. 2011;47:S588   Crossref logo
Link1 Link2

Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis
BMC Cancer. 2010;10(1):   Crossref logo
Link1 Link2 Link3

Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial
OncoTargets and Therapy. 2014;1551   Crossref logo
Link1

Clinical outcomes with bevacizumab-containing and non-bevacizumab–containing regimens in patients with recurrent glioblastoma from US community practices
Journal of Neuro-Oncology. 2015;122(3):595-605   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.